Track: COVID19 and Diabetes

Diabetes 2026

Session Overview

This session provides an overview of the bidirectional relationship between COVID-19 and diabetes, including the mechanisms through which infection can affect pancreatic function and immune response. It highlights evidence-based strategies for managing diabetes during COVID-19 infection and discusses the long-term implications of post-COVID metabolic complications.


Key Topics

Impact of COVID-19 on Glycemic Control: COVID-19 infection can lead to stress-induced hyperglycemia and worsen metabolic control, requiring adjustments in diabetes treatment and monitoring.


COVID-19 Severity and Diabetes-related Risk: People with diabetes are at higher risk for severe COVID-19 outcomes, including hospitalization, ICU admission, and mortality, particularly when glycemic control is poor.


New-onset Diabetes Post-COVID: SARS-CoV-2 may affect pancreatic beta cells and metabolic regulation, potentially leading to new-onset diabetes in some patients after infection.


Vaccination and Diabetes Management: Vaccination remains a key preventive measure, and proper diabetes management during vaccination is essential to minimize adverse effects and ensure optimal immune response.


Post-COVID Complications and Recovery: Long-term metabolic and cardiovascular complications may occur after COVID-19 infection, highlighting the need for ongoing follow-up and multidisciplinary care.


Learning Objectives

Participants will understand the relationship between COVID-19 infection and diabetes, including mechanisms affecting glycemic control and disease severity. The session aims to enhance knowledge of management strategies for diabetes patients during COVID-19 and the role of vaccination in prevention. Attendees will learn how to identify and manage post-COVID metabolic complications. The session also emphasizes the importance of integrated care approaches to reduce risks in vulnerable populations.